US 12,205,677 B2
System and method for analysis of biological data
Kfir Oved, Hof HaCarmel (IL); Eran Eden, Haifa (IL); Roy Navon, Tel-Aviv (IL); Assaf Cohen-Dotan, Natania (IL); Gali Kronenfeld, Tirat Carmel (IL); and Olga Boico, Haifa (IL)
Assigned to MeMed Diagnostics Ltd., Tirat HaCarmel (IL)
Appl. No. 16/324,562
Filed by MeMed Diagnostics Ltd., Tirat HaCarmel (IL)
PCT Filed Aug. 10, 2017, PCT No. PCT/IL2017/050886
§ 371(c)(1), (2) Date Feb. 10, 2019,
PCT Pub. No. WO2018/029690, PCT Pub. Date Feb. 15, 2018.
Claims priority of provisional application 62/372,820, filed on Aug. 10, 2016.
Prior Publication US 2019/0180846 A1, Jun. 13, 2019
Int. Cl. G16B 40/20 (2019.01); G01N 33/569 (2006.01); G16H 10/40 (2018.01)
CPC G16B 40/20 (2019.02) [G01N 33/569 (2013.01); G01N 2333/4737 (2013.01); G01N 2333/91091 (2013.01); G16H 10/40 (2018.01)] 29 Claims
 
1. A method of analyzing biological data, the method comprising:
obtaining biological data containing at least an expression level of MX dynamin-like GTPase 1 (MX1) and an expression level of C-reactive protein (CRP) in the blood of a subject;
calculating by a hardware processor a distance between a segment of a curved line and an axis defined by a direction, said distance being calculated perpendicularly to said axis, between a point on said axis and a corresponding point over said curved line, said points being defined by a coordinate δ along said direction, wherein said coordinate δ, once calculated, equals a0+a1X+a2ZMX1, and wherein said X is a value of said CRP in μg/ml, and said ZMX1 is a z-score of said MX1 relative to a group of subjects previously diagnosed with a bacterial infection;
storing said distance in a memory;
by said hardware processor, correlating said distance to the presence of, absence of, or likelihood that the subject has, a bacterial infection;
generating on a graphical user interface an output of said presence, absence or likelihood;
obtaining said likelihood based on said distance;
comparing said likelihood to a predetermined threshold; and
treating the subject for said bacterial infection with an antibiotic agent when said likelihood is above said predetermined threshold;
wherein at least 90% of said segment is between a lower bound line f(δ)−ε0 and an upper bound line f(δ)+ε1, wherein said f(δ) equals 1/(1+exp (−δ)), wherein each of said ε0 and said ε1 is less than 0.5, and wherein a0 is from about −2.4 to about −1.9, a1 is from about 0.04 to about 0.05, and a2 is from about −0.39 to about −0.43.